An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.
Source summary generated July 17, 2026; this date does not indicate completed review.
Quotes from three independent practitioners, with their sources. Research context only.
What it is and how it works
From the published literature on DHEA; the papers are listed at the end. Research summary, not a recommendation.
What it is
DHEA (dehydroepiandrosterone) is a steroid hormone made mainly by the adrenal glands from cholesterol, and in the blood it circulates mostly as its sulfate form, DHEA-S. It is not a peptide. Blood levels peak in early adulthood and fall steadily with age, which led to decades of research on whether replacing it slows aging. In the United States it is sold over the counter as a dietary supplement, and a vaginal form called prasterone is an FDA-approved prescription drug.
How it works
DHEA has weak hormone activity of its own and acts mainly as a precursor: enzymes inside tissues such as skin, bone, fat and the vagina convert it into testosterone and estrogens, a local process researchers call intracrinology. Because the conversion happens in the target tissue, a small rise in blood testosterone or estradiol can underestimate the effect in that tissue. A meta-analysis of randomized trials found that oral DHEA raised blood estradiol in women, with a larger rise in older and postmenopausal women. DHEA and DHEA-S have also been reported to act on brain receptors (GABA-A and NMDA receptors, which regulate nerve-cell excitability), which is the basis of the cognition and mood research.
What it has been studied for
Menopausal symptoms, sexual function and quality of life (Cochrane review)
Vaginal atrophy and painful intercourse after menopause (prasterone trials)
Body composition, strength and insulin sensitivity in older adults (two-year RCT)
Quality of life in women with adrenal insufficiency (meta-analysis)
Cognitive function in healthy older people (Cochrane review)
Poor ovarian response in IVF (Cochrane review)
Strength of the evidence
Approved drugVaginal prasterone (DHEA) is FDA-approved for painful intercourse due to menopause, and oral DHEA has been tested in many randomized controlled trials summarized in Cochrane reviews.
What the literature reports on safety
Cochrane and trial reviews reported androgenic side effects in women, mainly acne and unwanted hair growth, and no consistent serious adverse signal in trials of up to two years; long-term safety, including effects on hormone-sensitive cancers, has not been established. Oral DHEA is regulated as a dietary supplement in the US, so product content is not verified by the FDA, while vaginal prasterone (Intrarosa) is an approved drug. DHEA is on the World Anti-Doping Agency prohibited list as an anabolic agent.
Review · Klinge CM, Clark BJ, et al. · Vitamins and Hormones (2018) · PMID 30029723
Reviewed how DHEA is made, how it is converted to sex steroids in tissues, the receptors it may act on directly, and the mixed results of supplementation trials.
Review · Scheffers CS, Armstrong S, et al. · Cochrane Database of Systematic Reviews (2015) · PMID 25879093
Found no evidence that DHEA improved quality of life, uncertainty about menopausal symptoms, a possible slight improvement in sexual function, and more androgenic side effects than placebo.
Review · Naik S, Lepine S, et al. · Cochrane Database of Systematic Reviews (2024) · PMID 38837771
Concluded that DHEA pretreatment likely made little to no difference to live birth or pregnancy rates in poor responders undergoing IVF, unlike testosterone.
Review · Alkatib AA, Cosma M, et al. · Journal of Clinical Endocrinology and Metabolism (2009) · PMID 19773400
DHEA produced a small and possibly trivial improvement in quality of life and depression in women with adrenal insufficiency and no effect on anxiety or sexual well-being.
Randomized trial · Nair KS, Rizza RA, et al. · New England Journal of Medicine (2006) · PMID 17050889
In a two-year placebo-controlled trial in older men and women, DHEA had no physiologically relevant benefit on body composition, physical performance, insulin sensitivity or quality of life.
In a phase III placebo-controlled trial in postmenopausal women, intravaginal prasterone improved vaginal cell maturation, vaginal pH and the most bothersome symptom while blood steroid levels stayed in the normal postmenopausal range; this trial program supported its FDA approval.
Review · Zhu Y, Qiu L, et al. · Steroids (2021) · PMID 34246664
Pooled randomized trials found that DHEA supplementation raised blood estradiol in women, with larger rises in women aged 60 and over and in postmenopausal women.
Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), written 2026-11-06.
Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.
What have the teachers said about DHEA? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.
AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.